Arrowhead Pharmaceuticals has unveiled highly anticipated pancreatitis results from a late-phase trial of plozasiran for a rare lipid disorder, several months after reporting topline data …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
FDA officials, academic researchers and drug developers gathered at the FDA’s headquarters on Monday to discuss the landscape for monitoring the safety and efficacy of
As the demand for GLP-1 based drugs grows, content about the new class of weight loss drugs on TikTok has fueled the flames of its
Share this article The approval means the treatment will be available across all 27 EU member states. Credit: Shutterstock / Karolis Kavolelis. Pfizer’s Elrexfio for